Consumer goods magnate Kimberly-Clark is making headlines with its planned 40 billion acquisition of Kenvue a company embroiled in lawsuits and scrutinized by the White House regarding its Tylenol product The controversy stems from allegations that the medication predominantly used in pregnant women and infants is tied to autism
